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The Effectiveness of Long-Term Psychoanalytic
Therapy: A Systematic Review of Empirical
Studies
Saskia de Maat, PhD, Frans de Jonghe, MD, PhD, Robert Schoevers, MD, PhD, and Jack Dekker, PhD
Background: There is a gap in the research literature on the effectiveness of long-term psychoanalytic
therapies (LPT). Aim: To present a systematic review of studies dealing with LPT effectiveness and
published from 1970 onward. Methods: A systematic literature search for studies dealing with the
effectiveness of individual LPT in ambulatory, adult patients. Data about the overall effectiveness
of LPT, its impact on symptom reduction, and its effect on personality changes were pooled both at
treatment termination and at follow-up, using effect sizes (ESs) and success rates. Results: We found
27 studies (n= 5063). Psychotherapy yielded large mean ESs (0.78 at termination; 0.94 at follow-up)
and high mean overall success rates (64% at termination; 55% at follow-up) in moderate/mixed
pathology. The mean ES was larger for symptom reduction (1.03) than for personality change
(0.54). In severe pathology, the results were similar. Psychoanalysis achieved large mean ESs (0.87
at termination; 1.18 at follow-up) and high mean overall success rates (71% at termination; 54% at
follow-up) in moderate pathology. The mean ES for symptom reduction was larger (1.38) than for
personality change (0.76). Conclusion: Our data suggest that LPT is effective treatment for a large
range of pathologies, with moderate to large effects. (HARV REV PSYCHIATRY 2009;17:1–23.)
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The effectiveness of long-term psychoanalytic therapies
(LPT)—consisting of psychoanalysis “proper” and long-term
psychoanalytic psychotherapy—has been studied from the
very beginning, including by Coriat,1 Fenichel,2 Kessel and
Hyman,3 Jones,4 Alexander,5 Knight,6 Schjelderup,7 Orgel,8
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Knapp and colleagues,9 Graham,10 Klein,11 Cremerius,12
Bieber and colleagues,13 Hamburg and colleagues,14 and
Feldman.15 These studies can be seen as the first attempts to
provide empirical evidence of LPT’s effectiveness, but they
do not meet contemporary criteria of scientific research. In
recent decades, efforts have been made to bring LPT effec-
tiveness research more into line with current standards of
evidence-based medicine.
Of the recent reviews and overviews in this field, several
are especially noteworthy. Bachrach and colleagues16 per-
formed an extensive review of literature dealing with the
effectiveness of psychoanalysis. They discussed at length the
methodology, design, and results of six systematic studies,
including a total of 550 patients. The authors found success
rates (meaning substantial therapeutic benefit) in the 60%
to 90% range, and significant effect sizes (ESs). Doidge17
conducted an overview of the empirical evidence for psycho-
analytic psychotherapies and psychoanalysis. He concluded:
“There is considerable experimental and clinical data for ef-
ficacy of a range of individual psychoanalytic psychother-
apies, from short-term psychoanalytic psychotherapy to
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long-term psychoanalytic psychotherapy and psychoanal-
ysis.” Fonagy’s Open Door Review18 described the study
designs and outcomes of scores of LPT studies. Its im-
portance is not easily overrated. It covered both process
and outcome studies in a wide variety of patient groups.
Probably because of the broad range of these studies, Fon-
agy did not pool the data or aim to reach general conclu-
sions. The clinical heterogeneity of the studies would cer-
tainly have precluded the latter. Fonagy evaluated each
study separately and listed the strengths and weaknesses
of the designs, but the methodological quality of the stud-
ies was not systematically assessed or expressed as a qual-
ity score. Doidge19 evaluated nine quantitative studies of
psychoanalysis and concluded that “for the properly cho-
sen patient, psychoanalysis is effective in terms of symp-
tom relief, character changes, and conflict resolution.” The
review of Leichsenring20 dealt with short-term psychody-
namic psychotherapy and long-term psychoanalytic therapy.
He identified 22 randomized, controlled trials (RCTs), all
of which dealt with short-term psychotherapy. In another
article, Leichsenring21 reviewed 4 studies of long-term psy-
choanalytic therapy that met the highest quality require-
ments for naturalistic effectiveness studies. He concluded
that LPT was more effective than shorter forms of psycho-
dynamic psychotherapy and that it yielded ESs that signifi-
cantly exceeded the effects of untreated or low-dose-treated
comparison groups. The strength of his study was that it
included only the highest level of evidence for effectiveness
studies. The data from individual studies were not pooled.
A recent meta-analysis of Leichsenring and Rabung22 ad-
dressed the effectiveness of long-term psychodynamic psy-
chotherapy in complex mental disorders. It is an important,
extensive, and well-performed meta-analysis that includes
23 studies involving 1,053 patients. The authors concluded
that long-term psychodynamic psychotherapy showed sig-
nificantly higher outcomes on several measures than shorter
forms of psychotherapy and that pre/post ESs of long-term
psychodynamic psychotherapy fell in a range between 0.78
and 1.98, reflecting, by definition, a large effect. The meta-
analysis concentrated on psychotherapy and did not address
psychoanalysis.
In short, the more recent reviews are of good quality,
but many of them do not pool the data (e.g., calculate mean
ESs or mean success rates) from individual studies. Reviews
including psychoanalysis are scarce. Although some reviews
explicitly address study quality, they do not use systematic
quality scores.
The aim of this article is to present a systematic review
of LPT studies (psychotherapy or psychoanalysis) published
between 1970 and 2007. To enhance clinical homogeneity,
we focus on individual, ambulatory LPT with adult patients
having “regular” indications for psychoanalytic therapy.
Whenever possible, we divide our results according to treat-
ment (psychoanalysis or psychotherapy), assessment source
(patient or therapist), outcome (symptom reduction or per-
sonality change), and severity of pathology (moderate/mixed
or severe [personality disorders]). We perform a systematic
assessment of study quality using an explicit quality crite-
rion. Furthermore, we attempt to pool the data about the
effectiveness of LPT. Our pooling is restricted to assessing
success rates and ESs in individual studies and to calcu-
lating their weighted means among comparable studies. Fi-
nally, we compare the results of studies meeting our quality
criterion with the results of lower-quality studies.
LONG-TERM PSYCHOANALYTIC THERAPIES
We define “long-term” as therapy consisting of at least 50
sessions and lasting at least one year. Psychoanalysis is
always long-term; psychotherapy can be short-term or long-
term. LPT therefore includes psychoanalysis and long-term
psychoanalytic, including psychodynamic, psychotherapy.
The shared feature of these treatments is that they are
rooted in psychoanalytic theories. We differentiate between
the two treatments according to principles generally ac-
cepted by psychoanalytic therapists. Two easily identifiable
aspects, therapy setting and session frequency, discriminate
between these types of LPT. In psychoanalysis “proper,” the
patient lies on a couch, and there are at least three sessions
a week. In psychotherapy, patients sit across from the thera-
pist, and there are no more than two sessions a week. Inter-
pretation is the hallmark of psychoanalysis; psychotherapy
moves on a continuum between the poles of interpretation
and support.
The ultimate goals of LPT are symptom reduction, pre-
vention of recurrence, better social functioning, higher qual-
ity of life, and higher life satisfaction, preferably for a long
time after treatment termination. These goals are by no
means specific to LPT. The distinctive feature of LPT lies
in its intermediate goals, which focus on bringing about
changes in some aspects of the patient’s personality. These
changes, meant to be lasting, should enable patients to meet
the problems of living more successfully and to make bet-
ter use of their personal potential and the opportunities
afforded by their lives. In other words, people’s vulnera-
bilities are reduced, and their strengths and resources are
developed. The aim of LPT is to stimulate this development.
Successful LPT does not, by definition, make patients hap-
pier; it enhances the possibility that patients will be happy
when there is reason to be. It also enhances the possibil-
ity of there being such reasons, since people are (up to a
certain point) the creators of their own circumstances and
of their attitudes toward those circumstances. In psycho-
analytic terms, the changes in personality are described
as: “structural change,” “personality change,” “personality
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reconstruction or construction,” or the development of a “co-
hesive,” “adult,” “integrated” self. Freud23 put it “simply”
when stating that psychosynthesis is the ultimate goal of
psychoanalysis (“So vollzieht sich bei dem analytisch Be-
handelten die Psychosynthese”).
METHODS
Literature Search Strategy
A literature search was conducted in Pubmed, Embase, the
Cochrane Database of Systematic Reviews, the Cochrane
Central Register of Controlled Trials, PsycLit, and the
ACP Journal Club. The following subject headings were ap-
plied: long-term psychotherapy, psychoanalysis, psychoana-
lytic psychotherapy, psychodynamic therapy. The time limit
was between 1970 and 2007 (May), with no limits set on lan-
guage. Cross-references in the retrieved publications were
tracked down. The Open Door Review18 was an important
source of studies regarding psychoanalytic therapies. There
was no systematic effort to find additional unpublished
data.
The following inclusion criteria were applied:
1. The studies were required to be “outcome-intervention
studies.” The outcomes had to be measured in terms of
symptom reduction or personality change. Issues such
as process variables or therapeutic variables were ex-
cluded from this review.
2. The studies were required to be RCT or cohort studies.
Case studies or case series were excluded, but surveys
(such as consumer reports or questionnaires among
therapists) were included.
3. The studies were required to deal with individual, am-
bulatory psychoanalytic therapies with adult patients
(18 to 65 years of age). Studies dealing with children
or the elderly, as well as studies conducted in clinical24
or day-care settings were excluded.
4. The studies were required to include patients with
regular indications for psychoanalytic therapies (i.e.,
DSM diagnoses [Axis I or II] or otherwise specified
symptoms or personality problems). We excluded psy-
chotherapeutic studies for psychotic disorders such as
schizophrenia;25 studies in connection with somatic
disorders such as juvenile-onset insuline-dependent
diabetes;26 studies with an exclusive focus on eating
disorders27 or on comparatively rare diagnoses such
as Munchhausen syndrome by proxy; and studies of
learning difficulties in children.28
5. Treatment was required to last a minimum of one
year and to involve at least 50 sessions.
Identification of Relevant Publications and Quality
Assessment
Two reviewers checked the search results (SdM and FdJ)
and requested all potentially suitable studies. They con-
ducted independent checks of all identified studies. Any dis-
agreements about whether a study should be included were
resolved by discussion with a third member of staff (JD).
The reviewers evaluated the quality of the studies indepen-
dently using a self-developed Research Quality Score (RQS;
see appendix). The list has not yet been validated beyond
the consensus between the two raters (SdM and FdJ) who
evaluated the quality of the studies. Its criteria, which are
based on those postulated by the Cochrane Collaboration29
and by Leichsenring,21 deal with study design, patients in-
cluded, interventions, outcome data, statistics, dropout, and
follow-up.
We defined half of the maximum RQS score to be the
minimum for selection as a study with acceptable research
quality. Since this cut-off score was ultimately arbitrary, we
also evaluated the studies falling below the cutoff score and
compared their results with those of the studies meeting
our criterion. We distinguish between three design types,
each with their own criteria (which overlap extensively),
maximum scores, and cutoff scores. A type 1 study is a co-
hort study without matched control groups, although it may
include multiple cohorts. A type 2 study is a cohort study
with a matched control group. A matched control group is
considered to be either an untreated, matched group with
characteristics highly similar to those of the intervention
group, or a matched group treated with a therapy that is
already considered evidence based. We classify studies with
both a psychotherapy group and a psychoanalysis group,
even if matched, as type 1 studies: a cohort study consisting
of two cohorts. The two groups cannot act as controls for
each other, as the indications for “psychoanalysis” versus
“psychotherapy”—which take into account considerations
such as ego strength, affect tolerance, and capacity for reflec-
tion and insight—make the two patient groups inherently
different. A type 3 study is a RCT. It goes without saying
that a type 3 study ranks higher than a type 2 study, which,
in turn, ranks higher than a type 1 study. By the same to-
ken, type 3 studies must achieve a higher cutoff score than
type 2 studies, and type 2 studies a higher cutoff score than
type 1 studies. Nevertheless, each study can be, within the
limits of its type, well designed and well performed—that is,
achieve the cutoff score appropriate for that research type.
In addition, the presence or absence of a follow-up phase is
considered a separate criterion from our RQS; otherwise, a
good study without follow-up could be discarded, whereas a
relatively flawed study with follow-up could be accepted.
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Effectiveness Data and Calculations of Results
We first summarized the findings of studies meeting our
quality criterion. The primary outcome data were pre/post
and pre-follow-up ESs,30 which we considered to be the most
“robust” outcome measures. First, they require pre- and
posttreatment assessments using a specific questionnaire,
and second, their standardization allows for comparison.
Consequently, since any particular ES expresses a particu-
lar degree of relative change, the amount of change in differ-
ent studies—on different scales in different populations—
can be compared. ESs less than 0.5 are considered small;
from 0.5 to 0.8, medium; and greater than 0.8, large.30 For
each study that presented more than one ES, a mean ES
for the study was calculated. The ESs of individual studies
were used, in turn, as the basis for calculating an overall
mean ES, with the individual study ESs weighted to reflect
the study’s sample size. As some outcome measures may be
more sensitive to change than others,31,32 we also calculated
separate mean ESs for scales concerning symptoms (e.g.,
the 90-item Symptom Checklist–90–Revised [SCL-90-R])33
and for scales considered to measure aspects of personal-
ity (e.g., the Sense of Coherence Scale [SOC]34 and Social
Adjustment Scale [SAS]).35
Success rates were adopted as the secondary outcome
measure. We consider measures of success rates to be less
“robust” since they consist of more general assessments
such as appraisals from patients and therapists of therapy
success. Scales and criteria varied per study. We defined
success as “at least moderate improvement.” Obviously, the
definition and interpretation of success varies, depending
on the scale used. Therefore we mention the scales used in
each individual study. Some scales are more global (such
as the five- or seven-step Likert scales used in the Clinical
Global Assessment [CGI])36 and do not always differentiate
between symptoms or personality changes. However, some
studies used symptom scales like the SCL-90-R to measure
success rates, and other studies used scales relating to
personality aspects (e.g., capacity to enjoy, interpersonal
capacities, or the capacity to deal with conflicts and in-
terpersonal relationships). Whenever possible, we divided
the results into general/symptom-related assessments and
personality-related assessments, and then divided these
results, in turn, into groups reflecting either therapist or
patient assessments. For each table, we also calculated
overall success rates, with the success rates of all studies
pooled and weighted to take into account the sample size in
each study.
Breakdown of the Results
We broke down our results using five types of differentiation:
1. psychoanalysis “proper” and psychoanalytic therapy
(referred to hereinafter as “psychotherapy”)
2. “therapist assessment” and “patient assessment”
3. pre/post outcomes and pre-follow-up outcomes, with
“post” defined as “at treatment termination,” and
follow-up as a given period after treatment termina-
tion
4. results relating to symptom reduction (e.g., SCL-90-R)
and results relating to personality change (e.g., SOC
or Inventory of Interpersonal Relationships [IIP])37
5. “moderate/mixed” pathology and “severe” pathology,
with “moderate/mixed” pathology reflecting patients
meeting the full range of “regular” indications for am-
bulatory LPT as indicated by the extensive survey of
Doidge and colleagues,38,39 and “severe” pathology be-
ing reserved for patients in studies that included only
patients with more severe personality disorders such
as borderline personality disorder
In the study just mentioned, the authors conducted a sur-
vey of 510 analysts in Australia, Canada, and the United
States.38,39 The results showed that 71% of the patients
had a DSM-III-R personality disorder, 68% a major depres-
sive disorder, and 57% an anxiety disorder. Only 3% of the
patients did not present a DSM-III-R diagnosis. In addi-
tion, comorbidity was high, with the modus of patients pre-
senting three disorders. Although these clinical pictures are
complicated diagnostically, we labeled pathology in patients
treated in ambulatory psychoanalytic practices to be “mod-
erate/mixed,” thereby conforming our usage to the findings
of Doidge and colleagues.38,39
RESULTS
A total of 742 studies was initially found. Based on screen-
ing of titles and abstracts, 672 studies were excluded in the
first selection round. Reasons for exclusion were as follows:
patients samples based on a somatic illness and not a psy-
chiatric illness; case studies; theoretical articles; epidemio-
logical studies; studies dealing with training of professional
therapists; studies dealing with alcohol and drugs; patient
samples concerning only geriatric or psychotic patients; rare
diagnoses such as Munchausen by proxy; and articles deal-
ing with methodological issues. The remaining 73 articles
were retrieved, and a further exclusion of 46 studies fol-
lowed in the second round. Reasons for exclusion in this
round were as follows: process-outcome studies; studies fo-
cusing on children; reviews; studies on short-term therapies;
studies focusing on therapist variables; and studies on inpa-
tients. Finally, 27 outcome studies were retrieved concern-
ing LPT in regular ambulatory patients. Table 1 presents
an overview of those 27 studies. Tables 2 to 4 show the re-
sults of the 19 studies that met the quality criterion. Table 5
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presents the results of the remaining 8 studies. Finally, Ta-
ble 6 summarizes all findings.
Included Studies
As can be seen in Table 1, we found 27 relevant publica-
tions meeting our inclusion and exclusion criteria. These
studies included 1 RCT, 5 surveys, and 21 cohort studies.
Of the cohort studies, 16 were prospective, and 5 retrospec-
tive. Four surveys45,51,52,54 were replications of the study by
Seligman.76 The survey by Stehle67 was based on inquiries
among therapists. In all, the studies covered 5,063 patients
(3,632 in psychotherapy, and 1,431 in psychoanalysis). The
mean number of sessions was approximately 500 (mean =
of 3.6 years, with approximately 140 sessions/year) in psy-
choanalysis and 150 (mean = 2.5 years, with approximately
60 sessions/year) in psychotherapy. The large majority of the
studies looked at patients with “moderate/mixed” pathology;
only five studies48,59,60,68,69 were considered to address “se-
vere pathology (only severe personality disorders).” In the
study of Keller,54 we categorized the psychoanalysis condi-
tion (n= 84) under the heading of “psychotherapy” because
the mean frequency of the sessions was 1.6 per week. For
similar reasons the study of Stehle67 was categorized un-
der psychotherapy, although some of the patients received
psychoanalysis.
Study Quality
A total of eight studies (30%)43−47,51,52,66,67 did not meet the
quality criterion (see appendix). Six of these studies were
retrospective studies, and five of them were surveys (sent
to either therapists or patients). The fact that the studies
were retrospective accounted for many of the low quality
scores. Other factors with a negative effect on the RQS of
studies were as follows: not stating inclusion and exclusion
criteria for patient selection, not describing the character-
istics of the patient sample or the treatment applied, no
intention-to-treat analyses, no independent or blind assess-
ments, not defining or describing dropouts, and moderate
quality of assessment instruments (e.g, only a five-step Lik-
ert scale addressing overall therapy success).
Of the remaining 19 studies, which met the quality
criterion, only 1 was an RCT.48 Two made an attempt
at a matched control group,20,53 and the other 16 were
single- or multiple-cohort studies. Examples of cohort stud-
ies meeting most of the quality criteria were the studies
of Brockman and colleagues,41 Grande and colleagues,49
and Leichsenring.20 The studies were well designed and
prospective; patient samples were clearly described; treat-
ments were described; treatment adherence was controlled
for (although not in Brockman and colleagues);41 assess-
ment instruments were well qualified; there were mul-
tiple assessors (although none of the studies included
blind assessment); follow-up results were included; and the
Leichsenring20 study attempted to compare the sample to a
control group.
LPT Effect Sizes
Tables 2.1 to 2.3 present the ESs for psychoanalysis and
psychotherapy in moderate/mixed studies and in those in-
cluding only patients with severe pathology.
As can be seen in Table 2.1, the majority of the studies of
psychotherapy for moderate/mixed pathology reported large
ESs, both at treatment termination (65%) and at follow-up
(69%). The weighted mean ESs were large at both termi-
nation (0.78) and follow-up (0.94). We calculated mean ESs
separately for symptom reduction and personality change
(scales marked S and P, respectively, in the table); scales
that provided only global assessments were not included in
the table (and are marked with dashes). All ESs at treat-
ment termination, as well as at follow-up, were included in
this calculation of the mean ESs. The weighted mean ESs
were 1.03 (n = 572; SD = 0.59) for symptom reduction and
0.54 (n= 599; SD = 0.33) for personality change.
As can be seen in Table 2.2, approximately half of the
studies dealing with psychotherapy in severe pathology re-
ported large ESs, both at treatment termination (46%) and
follow-up (56%). The weighted mean ESs were large at both
termination (0.94) and follow-up (1.02). However, the latter
was a result from only one study. The majority of the stud-
ies dealt with personality aspects. Leaving out the one study
with no results concerning personality change and using all
other ESs, the overall ES for personality change was 1.11
(n= 67; SD = 0.02).
As can be seen in Table 2.3, which regards psychoanal-
ysis for moderate/mixed pathology, 50% of the studies re-
ported large ESs at treatment termination, whereas 80% of
the studies reported large ESs at follow-up. The weighted
mean ESs were large both at termination (0.87) and at
follow-up (1.18). We made separate calculations of mean ESs
for symptom reduction and for personality change. All ESs
at treatment termination and at follow-up were included
in these calculations. The weighted mean ESs were 1.38
(n = 150; SD = 0.27) for symptom reduction and 0.76 (n =
186; SD = 0.27) for personality change. Since the study of
Weber72 presented ESs for only part of the psychoanalysis
group (range, 0.40–0.50), we did not include them in the ta-
ble. We did not find ES data for psychoanalysis for severe
pathology.
LPT Success Rates
Symptom-related or general assessments. Tables 3.1 to 3.4 pre-
sent the success rates for psychoanalysis and psychotherapy
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TABLE 2.1. Psychotherapy Effect Sizes for Studies with Moderate/Mixed Pathology
Pre/post ESa Pre-follow-up ESa Mean ES
Study n Scale: P/Sb Small Medium Large Small Medium Large Post Follow-up
Brockman et al.
(2003)40
31 SCL-90-R (GSI): S
IIP (relationships): P
1.37 1.28
Brockman et al.
(2002)41c
1.19
Grande et al. (2006)49 27 SCL-90-R (GSI): S 0.92 1.04 0.80 0.95 (1 yr)
IIP (relationships): P 0.67 0.85
Holm-Hadulla et al.
(1997)53
37 Global judgment by
patient: −
1.13 1.05
Global judgment by
therapist: −
0.96
Keller et al. (1998)54 111 BSS: S 2.10 2.10 (6 yrs)
Leichsenring et al.
(2005)55
36 SCL-90-R (GSI): S 1.34 1.38 1.64 1.88 (1 yr)
IIP (relationships): P 1.28 1.85
Life satisfaction: P 1.55 1.81
GAS: − 2.39 2.48
Sandell et al. (2000)65 331 SCL-90-R: S 0.60 0.46 (3 yrs)
SOC: P 0.34
SAS: P 0.44
Weber et al. (1985)72 138 Ego strength: P 0.59
Social relations: P 0.43 0.51
Work gratification: P 0.50
Weber et al. (1985)74 29 Ego strength: P 0.11 0.11
Wilczek et al. (2004)75 36 KAPP: P 0.30 0.82 (0.5 yr)
KSP: P 0.40
GAF: − 0.87
CPRS (anxiety): S 0.99
CPRS (depression): S 1.23
CPRS (obsessive-
compulsive): S
1.10
Total 776
Percentage of ES 14% 21% 65% 25% 6% 69%
Weighted Mean ES (n) 0.78 (298) 0.94 (541)
Minimum 0.11 0.46
Maximum 1.64 2.10
Standard deviation 0.45 0.69
Mean duration
follow-up
3.2 yrs
BSS, Beschwerden-Schwere-Score; CPRS, Comprehensive Psychopathological Self-Rating Scale for Affective Syndromes; ES, effect size;
GAS, Goal Attainment Scale; GSI, General Severity Index; IIP, Inventory of Interpersonal Problems; KAPP, Karolinska Psychodynamic
Profile; KSP, Karolinska Scales of Personality; SAS, Social Adjustment Scale; SCL-90-R, Symptom Checklist–90–Revised; SOC, Sense of
Coherence Scale; yr, year.
a Small < 0.5; 0.5 < medium < 0.8; large > 0.8.
b P = scale mostly related to personality aspects; S = scale mostly related to symptoms; “−” denotes global outcome.
c After 3.5 years in therapy.
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TABLE 2.2. Psychotherapy Effect Sizes for Studies Regarding Only Severe Personality Disorders (Severe Pathology)
Pre/post ESa Pre-follow-up ESa Mean ES
Study n Scale: P/Sb Small Medium Large Small Medium Large Post Follow-up
Clarkin et al.
(2001)42
23 Self-injurious behavior (no.
of incidents): S
0.15 0.33
Medical risk of incidents: − 0.37
Physical condition after
incidents: −
0.46
Giesen-Bloo et al.
(2006)48c
42 BPDSI: P 1.85 1.12
EuroQol: P 0.64
WHOQOL: P 1.16
Psychopathology and
personality pathology: P
0.84
Monsen et al. (1995,
1995)59,60
25 MMPI (depression): P 0.67 0.67 1.20 1.02 (5.2 yrs)
MMPI (anxiety): P 0.78 0.78
MMPI (ego resilience): P 1.45
MMPI (ego strength): P 1.15
MMPI (social withdrawal): P 0.92 0.92
Affect consciousness: P 2.46 2.30
Morey PD scale (MMPI)
(passive-aggressive,
borderline, antisocial,
compulsive, paranoid): P
0.91
Morey PD scale (MMPI)
(avoidant, dependent,
schizoid): P
0.54
Morey PD scale (MMPI)
(histrionic, narcissistic): P
0.49
Total 90
Percentage of ES 27% 27% 46% 11% 33% 56%
Weighted mean ES (n) 0.94 (90) 1.02 (25)
Minimum 0.33 1.02
Maximum 1.20 1.02
Standard
deviation
0.36 0.00
Mean duration
follow-up
5.2 yrs
BPDSI-IV, Borderline Personality Disorder Structured Interview; ES, effect size; EuroQol, European Quality of Life thermometer; MMPI,
Minnesota Multiphasic Personality Inventory; PD, personality disorder; WHOQOL, World Health Organization Quality of Life assessment;
yr, year.
a Small < 0.5; 0.5 < medium < 0.8; large > 0.8.
b P = scale mostly related to personality aspects; S = scale mostly related to symptoms; “−” denotes global outcome.
c Three years in treatment.
in moderate/mixed pathology on the basis of therapist
and patient opinions about symptom reduction and over-
all health state. As can be seen in Tables 3.1 and 3.2, for
psychotherapy in moderate/mixed pathology, success rates
at treatment termination ranged between 30% and 95%
(weighted mean = 69%) according to therapists, and be-
tween 33% and 93% (weighted mean = 59%) according to
patients. A lack of data meant that follow-up success rates
could not be calculated.
Turning to the success of psychotherapy for severe
pathology, Monsen and colleagues59,60 reported a reduction
of DSM Axis I disorders of 75% at treatment termination
and of 83% at follow-up, as rated by independent observers
(mean = 79%). In addition, 76% of the patients in the study
did not meet the caseness criterion of the SCL-90-R’s Global
Severity Index at follow-up.
As can be seen in Tables 3.3 and 3.4, for psychoanaly-
sis in moderate/mixed pathology, success rates at treatment
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TABLE 2.3. Psychoanalysis Effect Sizes for Studies with Moderate/Mixed Pathology
Pre/posta Pre-follow-up Mean ES
Study n Scale: P/Sb Small Medium Large Small Medium Large Post Follow-up
Grande et al.
(2006)49
32 SCL-90-R (GSI): S 1.54 1.58 1.38 1.44 (1 yr)
IIP (relationships): P 1.22 1.30
Rudolf et al.
(1994)64
44 PSKB-Se (somatic
anxiety): S
1.36 0.90
PSKB-Se (depression): S 0.94
PSKB-Se (somatic
complaints): S
0.80
PSKB-Se (social anxiety): S 0.78
PSKB-Se (regressive
attachment): P
0.62
Sandell et al.
(2000)65
74 SCL-90-R: S 1.55 1.06 (3 yrs)
SOC: P 1.18
SAS: P 0.45
Weber et al.
(1985)74
36 Ego strength: P 0.39 0.39
Total 186
Percentage of ES 12.5% 37.5% 50% 20% 0% 80%
Weighted mean ES (n) 0.87 (112) 1.18 (106)
Minimum 0.39 1.06
Maximum 1.38 1.44
Standard
deviation
0.41 0.17
Mean duration
follow-up
2.6 yrs
ES, effect size; GSI (General Severity Index); PSKB-Se, Psychischer und Sozial-Kommunikativer Befund–Selbstbeurteilung; SAS, Social
Adjustment Scale; SCL-90-R, Symptom Checklist–90–Revised; SOC, Sense of Coherence Scale; yr, year.
a Small < 0.5; 0.5 < medium < 0.8; large > 0.8.
b P = scale mostly related to personality aspects; S = scale mostly related to symptoms; “−” denotes global outcome.
TABLE 3.1. Therapist Opinions of Psychotherapy Successa Rates (Symptoms/General Assessments)
Study n Scale Post Follow-up
Holm-Hadulla et al.(1997)53 37 CGI (symptoms) 89% NA
Keller et al. (1998)54 111 Global assessment of overall health
state
95% NA
Leichsenring et al. (2005)55 36 CGI 84% NA
Leuzinger-Bohleber et al. (2001)56 194 CGI 67% NA
Von Rad et al. (1998)61 33 CGI 30% 55% (3.5 yrs)b
Rudolf et al. (1994)64 56 PSKB-Se 44% NA
Weber et al. (1985)72 138 CGI 61% NA
Weber et al. (1985)74 29 CGI 66% NA
Total 634
Mean % 69%
Range 30%–95%
CGI, Clinical Global Impression; NA, not available; PSKB-Se, Psychischer und Sozial-Kommunikativer Befund–Selbstbeurteilung; yr,
year.
a Success = at least moderate improvement on the scale concerned
b Rating by independent observers.
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TABLE 3.2. Patient Opinions of Psychotherapy Successa Rates (Symptoms/General Assessments)
Study n Scale Post Follow-up
Brockman et al. (2003)40 31 SCL-90-R (GSI) 60% NA
Brockman et al. (2002)41
Grande et al. (2006)49 27 SCL-90-R (GSI) 56% 56% (1 yr)
Holm-Hadulla et al. (1997)53 37 CGI (symptoms) 85% NA
Keller et al. (1998)54 111 Global assessment of overall health state 93% NA
Leichsenring et al. (2005)55 36 SCL-90-R (GSI) 77% NA
Leuzinger-Bohleber et al. (2001)56 194 CGI 64% NA
Rudolf et al. (1994)64 56 PSKB-Se 55% NA
Sandell et al. (2000)65 222b No longer meeting caseness criterionb 33% NA
Total
Mean
Range
714
59%
33%–93%
CGI, Clinical Global Impression; GSI, Global Severity Index; NA, not available; PSKB-Se, Psychischer und Sozial-Kommunikativer
Befund–Selbstbeurteilung; SAS, Social Adjustment Scale; SCL-90-R, Symptom Checklist–90–Revised; SOC, Sense of Coherence Scale; yr,
year.
a Success = at least moderate improvement on the scale concerned.
b The n here is the number of actual cases in the study, with cases falling in the lowest 10% on the SCL, SOC, and SAS.
termination ranged between 57% and 96% (weighted mean
= 70%) according to therapists, and between 66% and 81%
(weighted mean = 73%) according to patients. Lack of data
precluded the calculation of follow-up success rates.
Personality-related assessments. Tables 4.1 to 4.3 present the
success rates of psychoanalysis and psychotherapy for mod-
erate/mixed pathology, based on therapist and patient as-
sessments of personality-related changes.
In psychotherapy for moderate/mixed pathology (Tables
4.1 and 4.2), the success rates stated by therapists at treat-
ment termination (weighted mean = 57%) were comparable
to those stated by patients (weighted mean = 59%).
With regard to psychotherapy for severe pathology,
Giesen-Bloo and colleagues48 reported a success rate of 43%
at treatment termination—which was the percentage of pa-
tients who achieved the reliable change criterion for bor-
derline personality disorder (BPD) measured by the BPD
Index–IV. At follow-up, Stevenson and Meares68 found a re-
duction of 30% in patients meeting the criteria for BPD. In
the study of Monsen and colleagues,59,60 78% of all patients
with Axis II diagnoses no longer met the criteria for that
diagnosis at treatment termination, and 74% no longer met
the criteria at follow-up. The weighted mean of the success
rates in these three studies was 51% (according to indepen-
dent observers).
There were only two studies of psychoanalysis (Table
4.3), each representing patient opinions, and resulting in
a weighted mean of 61%. The studies dealt with moder-
ate/mixed pathology. There were no studies dealing with
TABLE 3.3. Therapist Opinions of Psychoanalysis Successa Rates (Symptoms/General Assessments)
Study n Scale Post Follow-up
Erle et al. (2003)44 92 CGI 66% NA
Leuzinger-Bohleber et al. (2001)56 207 CGI 60% NA
Luborsky (2001)58 17 SSI 65% NA
Von Rad et al. (1998)61 23 CGI 57% 30% (3.5 yrs)
Rudolf et al. (1994)64 44 PSKB-Se 64% NA
Weber et al. (1985)72 235 CGI 67% NA
Weber et al. (1985)74 36 CGI 96% NA
Total
Mean
Range
610
70%
57%–96%
CGI, Clinical Global Impression; NA, not available; PSKB-Se, Psychischer und Sozial-Kommunikativer Befund–Selbstbeurteilung; SSI,
Combination of “success,” “satisfaction,” and “improvement”; yr, year.
a Success = at least moderate improvement on the scale concerned.
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TABLE 3.4. Patient Opinions of Psychoanalysis Successa
Rates (Symptoms/General Assessments)
Study n Scale Post Follow-up
Grande et al.
(2006)49
32 SCL-90-R (GSI) 81% 72%
(1 year)
Leuzinger-
Bohleber et al.
(2001)56
207 CGI 73% NA
Rudolf et al.
(1994)64
44 PSKB-Se 75% NA
Sandell et al.
(2000)65
65b No longer meeting
caseness criterionb
66% NA
Total
Weighted mean
348
73%
Range 66%–81%
a Success = at least moderate improvement on the scale con-
cerned.
b The nhere is the number of actual cases in the study, with cases
falling in the lowest 10% on the SCL-90, SOC, and SAS.
therapist assessments of personality changes in mod-
erate/mixed pathology, and no studies regarding severe
pathology.
Overall Success Rates. We calculated overall success rates
by pooling all rates. In psychotherapy for moderate/mixed
pathology, the success rates were 64% at termination and
55% at follow-up. In psychotherapy for severe pathol-
ogy (only four studies available),48,59,60,68,69 the overall
success rates were 61% both at termination and at
follow-up.
In psychoanalysis for moderate/mixed pathology, the
pre/post success rate was 71%, and the pre-follow-up suc-
cess rate was 54%. In psychoanalysis for severe pathology,
TABLE 4.1. Therapist Opinions of Psychotherapy Successa
Rates (Personality-Related Assessments)
Study n Scale Post Mean
Holm-Hadulla et al.
(1997)53
37 CGI (conflicts) 60% 55%
CGI (reality) 49%
Leichsenring et al.
(2005)55
36 Interpersonal capacities 53% 60%
Capacity to work 53%
Capacity to enjoy 53%
Capacity to deal 79%
with conflict
Total
Mean
Range
73
49%–79%
57%
CGI, Clinical Global Impression.
a Success = at least moderate improvement on the scale con-
cerned.
TABLE 4.2. Patient Opinions of Psychotherapy Successa Rates
(Personality-Related Assessments)
Study n Scale Post Mean
Brockman et al.
(2003)40
31 IIP 32% 32%
Brockman (2002)41
Grande et al. (2006)49 27 IIP 50% 50%
Holm-Hadulla et al.
(1997)53
37 CGI (conflicts) 84% 75%
CGI (reality) 65%
Keller et al. (1998)54 111 Emotional condition 94% 72%
Physical condition 66%
Global health 51%
Satisfaction job 74%
Satisfaction partner 75%
Rudolf et al. (1994)64 56 Somatic problems 60% 40%
Mental problems 41%
Relational problems 20%
Total
Mean
Range
262
20%–94%
59%
CGI, Clinical Global Impression; IIP, Inventory of Interpersonal
Problems.
a Success = at least moderate improvement on the scale con-
cerned.
only one study was found,69 with a 59% success rate at treat-
ment termination.
Outcomes of Lower-Quality Studies
Tables 5.1 and 5.2 present the outcomes from studies not
meeting the quality criterion.
In psychotherapy, pre/post success rates ranged from
55% to 88%, with a mean of 69%. In psychoanalysis, the
range was 41% to 75%, with a mean of 67%. Freedman
and colleagues45 and Hartman and Zepf51 used a Mean
Effectiveness Score. The authors describe this measure as,
TABLE 4.3. Patient Opinions of Psychoanalysis Successa
Rates (Personality-Related Assessments)
Study n Scale Post Mean
Grande et al. (2006)49 32 Reliable Change 72% 72%
Index
IIP
Rudolf et al. (1994)64 56 Somatic problems 80% 55%
Mental problems 44%
Relational problems 41%
Total
Mean
Range
88
41%–80%
61%
IIP, Inventory of Interpersonal Problems.
a Success = at least moderate improvement the scale concerned.
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TABLE 5.1. Outcomes of Excluded Studies: Psychotherapy
A. Changes in Scores
n Pre Post Follow-up Pre/post Pre-follow-up
Heinzel et al. (1998)52 633
Physical healtha 3.20 2.20 2.13 31% 33%
General well-beinga 4.32 2.25 2.16 48% 50%
Mental healtha 4.45 2.26 2.18 49% 51%
Social functioninga 3.67 2.41 2.14 34% 42%
Du¨hrssen (1986)43 60
Symptoms (GBB) 73b 30c 41%
Personality (CGI) 8b 4c 50%
Personality (FPI) 12b 4c 33%
Friedman et al. (2005)47 551
GAF (0–100) 60.36 76.96 28%
B. Success Rates
n Scale Pre/Post Mean
Stehle (2004)7d 581 CGI (general) 88% 81%
CGI (symptoms) 85%
CGI (personality) 69%
Hartman & Zepf (2004)51e 448 CGI (success) 55% 55%
Total
Mean success rate
Range
1029
55%–88%
69%
CGI, Clinical Global Impression; FPI, Freiburger Perso¨nlichkeitsinventar; GAF, Global Assessment of Functioning; GBB, Giessener
Beschwerde Bogen.
a Scale: 1 = very good; 5 = very bad.
b Number of pretreatment symptoms.
c Number of improved symptoms.
d Although 61% of patients received psychoanalysis, only 20% had 3–4 sessions a week; 80% had only 1–2 sessions a week. This study
was therefore categorized under psychotherapy.
e 7% still in treatment.
in essence, a treatment satisfaction scale, with a maximum
of 300 points; 150 points indicated no effectiveness, and
below 150 indicated negative effectiveness. Freedman and
colleagues45 found a mean score of 209. Hartman and Zepf51
found a mean score of 237 in psychotherapy and 244 in
psychoanalysis.
Summary of Results
We summarize all the findings of this review in Table 6.
DISCUSSION
We conducted a systematic search of the literature between
1970 and 2007 for outcome-intervention studies of LPT
effectiveness in ambulatory, adult patients. We found 27
relevant studies. We classified 8 of them (30%) as “lower
quality” studies using a quality criterion based on a self-
developed research quality control list. We compiled the
results of the 19 “higher quality” studies by pooling their
data. First, we calculated overall ESs and success rates.
Second, we broke down the results according to symptom re-
duction/personality change, and therapist/patient opinion.
Psychotherapy
In moderate/mixed pathology, the overall success rates
(64% at termination; 55% at follow-up), the percentage of
large ESs (65% at termination; 69% at follow-up), and the
weighted mean ESs (0.78 at termination; 0.94 at follow-up)
indicate substantial effectiveness, which was maintained for
years after treatment termination. In severe pathology, tak-
ing into consideration that the results mainly related to
personality pathology, the percentage of large ESs (46% at
termination; 56% at follow-up) and the weighted mean ESs
(0.94 at termination; 1.02 at follow-up) were certainly not
inferior to those in moderate/mixed pathology. However, the
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TABLE 5.2. Outcomes of Excluded Studies: Psychoanalysis
A. Changes in Scores
n Pre Post Follow-up Pre/post Pre-follow-up
Du¨hrssen (1986)43 60
Symptoms (GB) 73a 26b 36%
Personality (CGI) 8a 4b 50%
Personality (FPI) 12a 3b 25%
B. Success Rates
n Scale Pre/post Mean
Erle & Goldberg (2003)44 161 CGI 74% 74%
Sashin et al. (1975)66 130 CGI (symptoms [discomfort]) 61% 54%
CGI (sexual adjustment) 51%
CGI (restriction of life functioning) 62%
CGI (interpersonal relationships) 41%
CGI (insight) 46%
CGI (work productivity) 43%
CGI (global) 75%
Hartman & Zepf (2004)51c 263 CGI 69% 69%
Total
Mean success rate
Range
554
41% –75%
67%
CGI, Clinical Global Impression; FPI, Freiburger Perso¨nlichkeitsinventar; GB, Giessener Beschwerde Bogen.
a Number of pretreatment symptoms.
b Number of improved symptoms.
c 67% still in treatment.
results in severe pathology should be interpreted cautiously,
as they are based on only three studies, with follow-up data
in only one study and with one of the studies presenting as
many as nine ESs. These ESs are likely to be highly corre-
lated since they present dimensions from only two separate
instruments.
When differentiating between symptom reduction and
personality changes, it appears that the effects for moder-
ate/mixed pathology were more pronounced for the former
(ES = 1.03) than for the latter (ES = 0.54). Patients and ther-
apists were in general agreement about success rates. They
both thought the effect on personality change was similar to
somewhat lower (59% and 57%, respectively) than that on
symptom reduction (59% and 69%, respectively).
As only a few studies presented data on severe pathol-
ogy, our findings were mainly suggestive. We found a large
weighted ES for personality change (1.11) and no ES in-
formation about symptom reduction. As with the results
for moderate/mixed pathology, success rates for personality
change seemed lower than for symptom reduction.
The recent, sophisticated meta-analysis of Leichsenring
& Rabung22 differs on several points from our review. First,
the cutoff date for studies considered was a year later than
ours (falling in 2008 rather than 2007), enabling it to con-
sider more recently published studies. Second, the focus was
explicitly on complex mental disorders—including, for in-
stance, eating disorders—whereas we left out these more
complex disorders. Third, the meta-analysis included both
ambulant patients and those receiving care in any form of
hospital setting, whereas we focused exclusive on the for-
mer. Fourth, the authors’ inclusion criteria were one year or
50 sessions (versus our one year and 50 sessions) and the
availability of information on ESs (versus our consideration
also of studies providing only response rates). As a result of
the different inclusion criteria, Leichsenring and Rabung22
considered 13 studies not included in our review. However,
it is noteworthy that the ESs for psychotherapy found by Le-
ichsenring and Rabung (0.78 to 1.98) were similar to the ESs
that we found (0.78 to 0.94). In addition, they also seem to
have found lower ESs for personality functioning (0.78) than
for symptoms (target problems, 1.54; psychiatric symptoms,
0.91). Finally, Leichsenring and Rabung confirmed our cau-
tious findings that results of psychotherapy were stable at
follow-up.
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TABLE 6. Summary of Results
A. Overall Effect Sizes and Success Rates
Psychotherapy Psychoanalysis
Mean
effect
size
% large
effect
sizes
Overall
success
rate
Mean
effect
size
% large
effect
sizes
Overall
success
rate
Mixed pathology (n= 9) (n= 11) (n= 4) (n= 8)
Termination 0.78 (n= 6) 65% 64% (n= 11) 0.87 (n= 3) 50% 71% (n= 8)
Follow-up 0.94 (n= 5) 69% 55% (n= 2) 1.18 (n= 2) 80% 54% (n= 2)
Severe pathology (only PDs) (n= 3) (n= 4) (n= 1)
Termination 0.94 (n= 3) 46% 61% (n= 3) NA NA 59% (n= 1)
Follow-up 1.02 (n= 1) 56% 61% (n= 2) NA NA NA
B. Effect Sizes and Success Rates for Symptom Reduction and Personality Change
Psychotherapy Psychoanalysis
Mean
effect
size
Success rate
according
to patient
Success rate
according to
therapist
Mean
effect
size
Successrate
according to
patient
Success rate
according to
therapist
Mixed pathology (n= 9) (n= 8) (n= 8) (n= 4) (n= 4) (n= 7)
Symptoms 1.03 (n= 6) 59% (n= 8) 69% (n= 8) 1.38 (n= 3) 73% (n= 4) 70% (n= 7)
Personality 0.54 (n= 7) 59% (n= 5) 57% (n= 2) 0.76 (n= 4) 61% (n= 2) NA
Severe pathology (only PDs) (n= 3) (n= 1) (n= 3)a
Symptoms NA 76% (n= 1) 79% (n= 1)a NA NA NA
Personality 1.11 (n= 2) NA 51% (n= 3)a NA NA NA
NA, not available; PD, personality disorder.
a Ratings made by independent observers.
Psychoanalysis
In moderate/mixed pathology, the overall success rates
(71% at termination; 54% at follow-up), the percentage of
large ESs (50% at termination; 80% at follow-up), and the
weighted mean ESs (0.87 at termination; 1.18 at follow-up)
indicated substantial effectiveness, which was maintained
for years after treatment termination. We did not find ESs
for psychoanalysis in severe pathology, and only one study
provided information about the success of psychoanalysis
for severe pathology: 59%.69
After differentiating between symptom reduction and
personality changes, we found that in moderate/mixed
pathology, the effects were more prominent for symptom re-
duction (ES = 1.38) than for personality changes (ES = 0.76)
(though these results, based on only four studies, must by
interpreted cautiously). Patients and therapists concurred
in their opinions about success rates, and the assessment of
changes in personality (61% and 51%, respectively) seemed
to be lower than the assessment of symptom reduction (73%
and 70%, respectively) (though note here, too, that the ef-
fects on personality change are based on only three studies).
Comparison with Outcomes of “Lower Quality” Studies
Thirty percent of the retrieved studies did not meet our
quality criterion. As only a few of them provided informa-
tion that could be compared to the results of the “higher
quality” studies, it is not possible to draw strong conclu-
sions. The data suggest that mean success rates do not
greatly differ from those in higher-quality studies. The mean
psychotherapy success rate was 69% in the lower-quality
studies and 67% in the higher-quality studies. For psycho-
analysis, the success rates were 67% and 67%, respectively.
Our findings concur with those of Lipsey and Wilson,77 who
concluded on the basis of 27 meta-analyses that the ESs
of studies of varying methodological quality did not differ
significantly.
Additional Comments
ESs for symptom reduction seem higher than for personality
change. This result accords with the findings in the litera-
ture and the findings of clinicians that personality change
is harder to achieve than symptom reduction. Rudolf and
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colleagues50,64 found that long-term psychoanalytic therapy
performed better than moderate-length psychoanalytic ther-
apy (mean = 60 sessions) in terms of structural changes of
personality. The results of a study by Kopta and colleagues78
showed that improvements in personality structure took
longer than symptom reduction. Perry and colleagues79 es-
timated the length of treatment needed if patients were no
longer to meet the criteria for PDs. They found that 50% of
the patients would recover after 1.3 years (or 92 sessions),
and 75% by 2.2 years (or 216 sessions). The results of our
review indicate similar success rates in personality changes.
In our opinion, even a moderate effect on personality charac-
teristics may be more important clinically (related to quality
of life, social functioning, and vulnerability to relapse in the
long run) than a large effect on symptoms.
In addition, our cutoff point for considering therapy as
long term must be taken into account—at least 50 sessions
over a year or more—to be sure, far less than average for
long-term psychoanalytic therapy. Consequently, in many
cases within the studies reviewed here, therapy may have
satisfied our criterion as being long term but without hav-
ing continued long enough to result in (much) personality
change.
Another issue is the durability of the results. The general
literature contains indications that the effects of short-term
therapies are themselves more short lived.80−82 In contrast,
our results suggest that the effects of LPT persist for years
after treatment termination.
The comparability of psychotherapy and psychoanalysis
remains unresolved; in our opinion, our findings do not al-
low for valid comparisons of the relative effectiveness of
psychotherapy and psychoanalysis. Little information was
provided that would allow a comparison of the psychother-
apy patient group and the psychoanalysis patient group in
terms of all relevant pretreatment characteristics. Since the
groups were not randomized, it is likely that the personality
traits of patients receiving psychotherapy and those receiv-
ing psychoanalysis differed in important respects.
Limitations
Our study presents several limitations. First, our review is
almost entirely based on cohort studies. In the hierarchy of
empirical evidence, RCTs are the gold standard, although
treatment RCTs are fraught with their own problems. It
has been extensively argued21,76,83−85 that it is difficult to
conduct RCTs of long-term therapies (be they psychologi-
cal or somatic). Treatments for borderline personality dis-
orders present somewhat fewer difficulties in this respect.
Leichsenring20 has cogently argued that when studying
long-term treatments, it is not possible to maintain a wait-
ing list of untreated patients, to apply manualized treat-
ments, or to create equal treatment conditions. He pointed
out that the personality characteristics of patients who opt
for long-term psychoanalytic therapy differ from those of
patients preferring other therapies. Randomization, even if
nominally feasible, violates the therapy-patient match.
Some argue that cohort studies tend to overestimate
treatment effect,86,87 but other studies contradict that view.
Concato and colleagues88 compared the results of RCTs to
those of cohort studies dealing with the same interventions
for five different somatic disorders. Analyses of 72 meta-
analyses of RCTs, 24 meta-analyses of cohort or case-control
studies, and 6 meta-analyses involving both designs showed
that the results of the observational studies were remark-
ably close to those of RCTs. The authors concluded: “The
popular belief that only randomised, controlled trials pro-
duce trustworthy results and that all observational studies
are misleading does a disservice to patient care, clinical in-
vestigation, and the education of health care professionals.”
Shadish and colleagues89 did not find a significant correla-
tion between the degree of clinical representativeness (i.e.,
RCTs vs. naturalistic studies) and the size of effects reported
in studies of psychotherapy. Benson & Hartz90 compared the
results of observational studies with those of RCTs reported
between 1985 and 1998 dealing with two or more treat-
ments or interventions for the same condition. The authors
concluded: “We found little evidence that estimates of treat-
ment effects in observational studies reported after 1984
are either consistently larger than or qualitatively different
from those obtained in randomized, controlled trials.”
A second limitation is that our review pools data from
studies that were conducted in different countries and set-
tings, at different times, and for different patients, and that
used nonmanualized therapies (i.e., ones that, despite be-
ing psychoanalytic, undoubtedly have different features).
Our results must therefore be interpreted with caution.
For the same reason, comparing pre/post findings with pre-
follow-up findings is hazardous since they typically refer
to different groups of patients. We have tried to enhance
the comparability of the studies included by restricting our
search to individual therapy in adult, ambulant patients, by
distinguishing between moderate/mixed and severe pathol-
ogy, and by applying a quality criterion. Nevertheless, the
studies included are still obviously characterized by clinical
heterogeneity (especially if measured by DSM diagnostic
standards). However, according to psychoanalytic diagnos-
tic criteria, the patient group shows more actual homogene-
ity. After all, all patients were indicated, presumably on
solid grounds, for psychoanalytic therapy. The recent Psy-
chodynamic Diagnostic Manual91 proposes conceptual and
research foundations for a psychodynamically based clas-
sification system for mental health disorders. The manual
includes, in connection with DSM categories, dimensions of
mental functioning such as capacity for emotion regulation,
capacity for relationships and intimacy, quality of internal
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experience (levels of self-confidence and self-regard), defen-
sive patterns, self-observing capacities, and capacity for dif-
ferentiation and integration. These dimensions represent
(some of) the diagnostic criteria that psychoanalysts use
when establishing whether psychoanalytic therapy is indi-
cated.
Third, most of the studies included in our review treated
patients with different diagnoses and with high levels of co-
morbidity. The studies did not always break down their re-
sults according to diagnostic categories. Some studies pro-
vided limited demographic and clinical information about
the patients. Both of these factors limit the conclusions we
can draw about the effectiveness of LPT for specific DSM-
specified disorders. Nevertheless, the diversity of patients
serves to enhance the representativeness of the patient pop-
ulation to that of general LPT clinical practice—which is
precisely the strength of naturalistic effectiveness studies.
A related consideration regarding the diagnostic aspects of
this review is that our description of studies as dealing with
“moderate/mixed” or “severe” pathology could be misleading.
Some patients with moderate/mixed pathology suffer from
severe disorders, and many of these patients have various
comorbid disorders—which means that complex clinical pic-
tures are the standard, not the exception. Many have also
tried briefer therapies, apparently to no avail.38,39
Fourth, the quality of the studies that met our inclusion
criteria varied. Unfortunately, the quality of any review—
including this one—depends heavily on the quality of the
studies included. In an effort to safeguard quality, we de-
vised a 24-item Research Quality Score inspired by the cri-
teria put forward by Leichsenring21 and by the Cochrane
Collaboration.29 We defined an admittedly arbitrary cutoff
point, and the list has not been validated. The rigorous-
ness of our quality check could therefore, in this respect, be
amenable to improvement. Thirty percent of the studies we
found in the literature did not meet our quality criterion—
which suggests that the RQS is doing some serious work—
but the quality of the studies that met our criterion never-
theless varied widely. Flaws included: the lack of pretreat-
ment data (retrospective design); an overgeneral description
of the patient population (e.g., stating only that the sample
included patients treated in a given period); no mention
of diagnoses; no detailed information about the therapies
(e.g., saying only that the study dealt with psychoanalysis
or psychotherapy, but not stating the mean number of ses-
sions or duration); overgeneral outcome criteria (e.g., using
only a five-step Likert scale for “therapy success”); no in-
dependent, let alone blind, assessors; no information about
dropouts (e.g., data only for completers); and no analyses of
confounders. Only two studies tried to provide some infor-
mation about control groups.20,53
Fifth, many studies used simple measures of success
rates—often comprising no more than global assessments
of success based on patient and therapist opinions. Some
studies did show that global assessment scales provided
more differentiation to reflect both the severity of the ill-
ness and treatment results,92 but such scales do not provide
the same information as detailed questionnaires; they are
simple instruments that often demand considerable clinical
competence to generate reliable information. Also reflecting
the nature of the studies themselves, success in our review
was rated predominantly by therapists and patients, and
only seldom by independent observers. There are pros and
cons, of course, for the rating provided by each group: pa-
tients, clinicians, and independent observers. On the one
hand, independent observers are less invested in the treat-
ment and might therefore be less biased in their judgment
of results. On the other hand, patients and therapists have
much more exposure than independent observers to the rel-
evant field of observation. In addition, since the patient’s
subjective feelings are integrally connected with the goals
of therapy, one may well wonder who should be the best
judge on any relevant improvement or success. The litera-
ture is not in agreement, however, on the question whether
patients and therapists might overestimate therapy success.
Harty and colleagues71 performed an analysis of the find-
ings of the Menninger Foundation’s psychotherapy research
project and found that both therapists (65%) and patients
(54%) rated therapy success higher than independent judges
(38%). Other studies have found, though, that self-reports
present more modest results than observer ratings.31,93
Sixth, the statistical analyses we performed were rather
simple. Although ESs are a reasonably robust evaluation of
treatment effects, we were limited to a simple calculation of
the average of the ESs reported in the individual studies.
For lack of the original data, we could not calculate mean
ESs based on the original means and standard deviations.
Furthermore, some of the pooled results are based on only a
few studies, and in some cases the results of only one study
are mentioned.
Finally, our decisions to categorize measures as involv-
ing symptom reduction versus personality changes may be
debated. In particular, success rates for symptom reduc-
tion were often based on CGI scales that do not necessarily
differentiate between symptom improvement and changes
in personality. We classified them as symptom reduction
measures.
CONCLUSIONS
LPT effectiveness has been extensively investigated, mainly
by cohort studies of varying quality. Our review of the avail-
able empirical evidence suggests that LPT is an effective
treatment modality, with moderate to large effects on both
symptom reduction and personality changes. The effects are
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stronger in symptom reduction than in personality change,
but moderate changes in personality may be more signifi-
cant clinically in terms of quality of life and relapse preven-
tion. Patients and therapists do not seem to differ in their
opinions about therapy success. The results of LPT seem
to be maintained in the years after treatment termination.
Further research with cohort studies will bear more fruit if
they incorporate stricter research standards.
Declaration of interest: The authors report no conflicts
of interest. The authors alone are responsible for the content
and writing of the article.
APPENDIX
Research Quality Score (RQS)
Cohort study with
Single or multiple matched control Randomized,
cohort study: group:a controlled trial:
Criteria Points Points Points
Study design
Randomization NA NA 35
Prospective design 10 10 NA
(Matched) control group NA 5, 10 NA
Patient group
Clear inclusion/exclusion criteria 0, 1, 2 0, 1, 2 0, 1, 2
Characteristics described 0, 1, 2 0, 1, 2 0, 1, 2
Baseline scores comparable NA 0, 2, 4 0, 2, 4
Adequate sample size 0, 1, 2 0, 1, 2 0, 1, 2
Intervention
Clear description of intervention 0, 2, 4 0, 2, 4 0, 2, 4
Therapist experience 0, 1, 2 0, 1, 2 0, 1, 2
Adherence therapist checked 0, 1, 2 0, 1, 2 0, 1, 2
Equal treatment groups NA 0, 2 0, 2
Outcome data
Outcome criteria clear and relevant 0, 2, 4 0, 2, 4 0, 2, 4
Quality assessment instruments 0, 2, 4 0, 2, 4 0, 2, 4
Blind or independent assessment 0, 2, 4 0, 2, 4 0, 2, 4
Multiple assessors 0, 2, 4 0, 2, 4 0, 2, 4
Statistics
Adequate statistical methods 0, 1, 2 0, 1, 2 0, 1, 2
ITT or PP analyses 0, 2, 4 0, 2, 4 0, 2, 4
Confounders analyses 0, 1, 2 0, 1, 2 NA
Dropout
Dropout defined and acceptable 0, 2, 4 0, 2, 4 0, 2, 4
Dropout comparable NA 0, 1, 2 0, 1, 2
Maximum RQS 52 70 83
Cutoff score review 26 35 41
Follow-up
Adequate length 0, 2, 4 0, 2, 4 0, 2, 4
Multiple assessors 0, 1, 2 0, 1, 2 0, 1, 2
Loss to follow-up defined and acceptable 0, 2, 4 NA NA
Loss to follow-up defined, acceptable, and comparable NA 0, 2, 4 0, 2, 4
(Maximum score for follow-up) 10 10 10
Maximum RQS 62 80 93
Cutoff score review 31 40 47
ITT, intent to treat; NA, not applicable; PP, per protocol.
a A matched control group is either an untreated, matched group (with similar features to those of the intervention group) or a group
treated with evidence-based treatment.
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